Superstring Capital Management LP Uro Gen Pharma Ltd. Transaction History
Superstring Capital Management LP
- $84.5 Billion
- Q2 2025
A detailed history of Superstring Capital Management LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Superstring Capital Management LP holds 87,912 shares of URGN stock, worth $1.69 Million. This represents 1.43% of its overall portfolio holdings.
Number of Shares
87,912
Previous 423,632
79.25%
Holding current value
$1.69 Million
Previous $4.69 Billion
74.29%
% of portfolio
1.43%
Previous 5.57%
Shares
5 transactions
Others Institutions Holding URGN
# of Institutions
158Shares Held
39.6MCall Options Held
2.02MPut Options Held
702K-
Rtw Investments, LP New York, NY4.54MShares$87.2 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$61.3 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$47.6 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$42.1 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...